Loading the SOTA2 catalog…
3D imaging device FDA-cleared as a transmission and reflection ultrasonic imaging system for the breast; 510(k) cleared as a supplementary screening device and for quantitativel...
3D imaging device FDA-cleared as a transmission and reflection ultrasonic imaging system for the breast; 510(k) cleared as a supplementary screening device and for quantitatively assessing breast fibroglandular volume and breast density; designated FDA Breakthrough Device in 2018.
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Loading community reviews…
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.